These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Metapramine: antidepressant and psycho-stimulant]. Bonierbale M; Dufour H; Scotto JC; Sutter JM Encephale; 1976; 2(3):219-23. PubMed ID: 1033059 [TBL] [Abstract][Full Text] [Related]
4. [Do brain hydrolysates potentiate the action of tricyclic antidepressive agents?]. Böhme K MMW Munch Med Wochenschr; 1975 Oct; 117(40):1311-2. PubMed ID: 810683 [No Abstract] [Full Text] [Related]
5. Pharmacotherapy of depression--a critical review. Ban TA Psychosomatics; 1975; 16(1):17-20. PubMed ID: 1101282 [No Abstract] [Full Text] [Related]
6. [Clinical study of a new antidepressive agent: 19560 RP]. Kammerer T; Singer L; Patris M Ann Med Psychol (Paris); 1975 Feb; 1(2):264-7. PubMed ID: 1232879 [No Abstract] [Full Text] [Related]
7. [Limits of efficacy and tolerance of antidepressive medications]. Ginestet D Encephale; 1975; 1(3):203-10. PubMed ID: 1227815 [TBL] [Abstract][Full Text] [Related]
8. [Extensive multicentric study of 1354 cases of depressed subjects treated with amineptin]. Deniker P; Besancon G; Colonna L; Coudert AJ; Danion JM; Dufour H; Escande M; Feline A; Fontan M; Gayral LF Encephale; 1982; 8(3):355-70. PubMed ID: 6764624 [TBL] [Abstract][Full Text] [Related]
9. [Comparative study of the pharmacological and clinical effects of clorimipramine and metaprimine (19560 R.P.)]. Dick P Encephale; 1978; 4(1):41-51. PubMed ID: 658012 [TBL] [Abstract][Full Text] [Related]
10. [Plasma levels of metapramine and its 3 major metabolites in patients with depression. Results and preliminary interpretations]. Bougerol T; Gouezo F; Pok Phak Rop P; Valli M; Durand A; Conquy T; Scotto JC; Viala A Encephale; 1990; 16(1):35-40. PubMed ID: 2328683 [TBL] [Abstract][Full Text] [Related]
12. Depression after 50. Fama PG N Z Med J; 1978 May; 87(612):361-3. PubMed ID: 276717 [No Abstract] [Full Text] [Related]
13. [Management of the therapy of depression with tricyclic antidepressive agents]. Gram LF; Kragh-Sørensen P; Nagy A; Dencker SJ; Lunde PK Ugeskr Laeger; 1981 Jan; 143(5):252-7. PubMed ID: 7210226 [No Abstract] [Full Text] [Related]
14. [Preliminary report on the terapeutic activity and clinical as well as biological tolerance of endovenous 34.276 Ba in melancholias and depressive conditions]. Volmat R; Allers G; Vittouris N; Dufoy F Schweiz Arch Neurol Neurochir Psychiatr; 1973; 113(2):410-5. PubMed ID: 4776681 [No Abstract] [Full Text] [Related]
15. Implications of therapeutic 'failure' with tricyclic antidepressants. Settle EC W V Med J; 1978 Apr; 74(4):78-80. PubMed ID: 273349 [No Abstract] [Full Text] [Related]
16. Clinical evaluation of a new tricyclic antidepressant iprindole. Ayd FJ Dis Nerv Syst; 1969 Dec; 30(12):818-24. PubMed ID: 4904943 [No Abstract] [Full Text] [Related]
17. [A test for using meta-analysis to evaluate antidepressive effects of fluoxetine]. Jarema M Psychiatr Pol; 1996; 30(4):569-81. PubMed ID: 8975258 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of mianserin (Lerivon) in various forms of depression. Florkowski A; Kocur J; Rydzyński Z Act Nerv Super (Praha); 1989 Apr; 31(1):25-6. PubMed ID: 2781993 [No Abstract] [Full Text] [Related]
19. [Clinical experimentation with a new antidepressive agent]. Ribustini G; Naim U Minerva Med; 1972 Nov; 63(83):4520-4. PubMed ID: 4565313 [No Abstract] [Full Text] [Related]